ad image

RepliGut

1 / 1
Exploring Pharmacokinetics and Safety for Drugs Targeting the Gut
Tissue Models

Exploring Pharmacokinetics and Safety for Drugs Targeting the Gut

Altis Biosystems

PAO-04-22-R250-03Apr 01, 2022
Altis Biosystems
Research Funding

Altis Biosystems Awards New Research Funding to Armed Forces Radiobiology Research Institute

Altis Biosystems

PR-M02-22-09Feb 09, 2022
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Tissue Models

Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Ron Laethem, Ph.D.

Altis Biosystems

PAO-02-21-CL-04Feb 18, 2021
The Power of RepliGut In Vitro Intestinal Stem Cell Models
Tissue Models

The Power of RepliGut In Vitro Intestinal Stem Cell Models

Bailey Zwarycz, Ph.D

Altis Biosystems

PA1081Jan 26, 2021
Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells
Preclinical

Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells

Ron Laethem, Ph.D.

Altis Biosystems

PAO-11-20-CL-01Dec 09, 2020
Enhancing Human Gut Tissue Models through Gene Editing
Gene Editing

Enhancing Human Gut Tissue Models through Gene Editing

Scott Magness, Ph.D.

Altis Biosystems

PAO-11-20-CL-03Nov 30, 2020
Evaluating Microbiome Therapies with Intestinal Cell Models
Microbiome

Evaluating Microbiome Therapies with Intestinal Cell Models

Scott Magness, Ph.D.

Altis Biosystems

PAO-10-20-CL-02Oct 22, 2020
Accelerating Drug Development with Microphysiological Systems (MPS)
Microphysiological Systems

Accelerating Drug Development with Microphysiological Systems (MPS)

Nancy Allbritton, Ph.D., M.D.

Altis Biosystems

PAP-Q3-20-CL-003Sep 29, 2020
1 / 1